Here are four points:
1. Additionally, Dr. Levy currently serves on the board of Gliknik, a privately held biopharmaceutical company.
2. Dr. Levy most recently served as executive vice president and chief drug development officer of Incyte.
3. He has also served as an assistant professor of medicine at the University of California Los Angeles School of Medicine.
4. Madrigal is a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for the treatment of cardiovascular, metabolic and liver diseases.
More articles on GI/endoscopy:
Jeannie Fahlquist joins Benefis Health GI team: 2 thoughts
Valeant, Norgine partner for bowel-cleansing solution; EndoChoice’s Q2 net loss totals $24.7M: 3 GI company key notes
Male PBC patients have higher mortality rates than female: 3 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.